Mirae Asset Global Investments Co., Ltd. Mersana Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,117 shares of MRSN stock, worth $3,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,117Holding current value
$3,170% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding MRSN
# of Institutions
125Shares Held
116MCall Options Held
233KPut Options Held
457K-
Eco R1 Capital, LLC San Francisco, CA19.4MShares$14.9 Million1.59% of portfolio
-
Nextech Invest Ag12.1MShares$9.29 Million3.72% of portfolio
-
Vr Adviser, LLC New York, NY11.3MShares$8.72 Million2.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$6.67 Million2.94% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$6.46 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $74.8M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...